drugset
drugset / Trial / NCT02597478

Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea

NCT02597478 ↗

Phase 2/3 Completed 50 enrolled M.D. Anderson Cancer Center INSYS Therapeutics Inc · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical research study is to learn if fentanyl can help shortness of breath in cancer patients. Researchers also want to learn if the study drug can help to improve your physical function.

Timeline

Start
2016-01-04
Primary completion
2018-09-27
Completion
2021-01-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 15 % Other
Subject Fentanyl Other / unclassified 25 % Other
Subject Fentanyl Other / unclassified 35 % Other
Subject Fentanyl Other / unclassified 45 % Other

Indications

cancer of unknown primary site